Kazuo Matsuura

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making.

A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making.

Journal: Palliative & supportive care

Published: May 14, 2026

Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.

Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.

Journal: Breast (Edinburgh, Scotland)

Published: April 20, 2026

Compartment-Specific CD138 Expression Defines an Aggressive Breast Cancer Phenotype with Distinct Transcriptomic Features.

Compartment-Specific CD138 Expression Defines an Aggressive Breast Cancer Phenotype with Distinct Transcriptomic Features.

Journal: Cancers

Published: April 02, 2026

Feasibility Study on Development of a Collaborative Monitoring System between a Hospital and Community Pharmacy Using an Electronic Patient-Reported Outcome Application for Breast Cancer Outpatients Treated with Abemaciclib.

Feasibility Study on Development of a Collaborative Monitoring System between a Hospital and Community Pharmacy Using an Electronic Patient-Reported Outcome Application for Breast Cancer Outpatients Treated with Abemaciclib.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: April 01, 2026

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment.

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment.

Journal: Cancer diagnosis & prognosis

Published: March 17, 2026

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

Journal: BMC cancer

Published: February 06, 2026

Septic Pulmonary Embolism due to Methicillin-Resistant Staphylococcus aureus Bacteremia during Adjuvant Chemotherapy for Breast Cancer: A Case Report.

Septic Pulmonary Embolism due to Methicillin-Resistant Staphylococcus aureus Bacteremia during Adjuvant Chemotherapy for Breast Cancer: A Case Report.

Journal: Case reports in oncology

Published: January 04, 2026

Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease.

Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease.

Journal: Breast (Edinburgh, Scotland)

Published: December 18, 2025

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.

Journal: Molecular and clinical oncology

Published: November 11, 2025

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer.

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer.

Journal: Frontiers in oncology

Published: August 01, 2025

G-CSF-induced Aortitis in an elderly woman successfully managed with prednisolone: a case report and literature review.

G-CSF-induced Aortitis in an elderly woman successfully managed with prednisolone: a case report and literature review.

Journal: Oxford medical case reports

Published: November 11, 2024

Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).

Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).

Journal: Breast cancer (Tokyo, Japan)

Published: September 20, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026